Yulong Han Selected Research

Yulong Han Research Topics

Disease

13	Neoplasms (Cancer) 10/2023 - 03/2007
5	Hepatocellular Carcinoma (Hepatoma) 01/2023 - 11/2020
4	Inflammation (Inflammations) 10/2023 - 12/2002
2	Carcinogenesis 01/2022 - 11/2020
2	Neoplasm Metastasis (Metastasis) 03/2021 - 11/2020
2	Chondrosarcoma 08/2013 - 02/2013
1	Ischemic Stroke 10/2023
1	Hyperthermia 10/2023
1	Fetal Growth Retardation (Intrauterine Growth Retardation) 07/2023
1	Wounds and Injuries (Trauma) 05/2023
1	Ovarian Neoplasms (Ovarian Cancer) 01/2022
1	Necrosis 12/2021
1	Hypoxia (Hypoxemia) 03/2021
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2021
1	Hypercholesterolemia 04/2016
1	Dyslipidemias (Dyslipidemia) 04/2016
1	Coinfection 08/2015
1	Osteosarcoma (Osteogenic Sarcoma) 02/2013
1	Leiomyoma (Uterine Fibroids) 06/2009
1	Glioblastoma (Glioblastoma Multiforme) 10/2007
1	Glioma (Gliomas) 10/2007
1	Brain Diseases (Brain Disorder) 12/2002
1	Multiple Sclerosis 12/2002
1	Meningoencephalitis 12/2002
1	Neurotoxicity Syndromes (Toxic Encephalopathy) 12/2002
1	Lyme Neuroborreliosis 12/2002

Drug/Important Bio-Agent (IBA)

3	CytokinesIBA 07/2023 - 03/2007
2	ChemokinesIBA 05/2023 - 11/2021
2	HydrogelsIBA 01/2023 - 08/2013
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 11/2020
2	CholesterolIBA 12/2021 - 04/2016
2	Proteins (Proteins, Gene)FDA Link 12/2021 - 06/2009
2	NF-kappa B (NF-kB)IBA 11/2021 - 10/2007
1	HDL CholesterolIBA 10/2023
1	CopperIBA 10/2023
1	Sulfides (Thioethers)IBA 10/2023
1	cupric sulfide (CuS)IBA 10/2023
1	Peptides (Polypeptides)IBA 05/2023
1	lenvatinibIBA 01/2023
1	Cisplatin (Platino)FDA LinkGeneric 01/2022
1	Annexin A5IBA 01/2022
1	PlatinumIBA 01/2022
1	Circular RNAIBA 01/2022
1	DNA (Deoxyribonucleic Acid)IBA 01/2022
1	Fas Ligand Protein (Fas Ligand)IBA 12/2021
1	Granzymes (Granzyme)IBA 12/2021
1	Interferon-gamma (Interferon, gamma)IBA 12/2021
1	fas Receptor (CD95 Antigen)IBA 12/2021
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 12/2021
1	Protein Kinases (Protein Kinase)IBA 11/2021
1	MAP-kinase-activated kinase 2IBA 11/2021
1	LigandsIBA 11/2021
1	Therapeutic UsesIBA 11/2021
1	HSP27 Heat-Shock ProteinsIBA 11/2021
1	Oxygen (Dioxygen)IBA 03/2021
1	Zn(II)-phthalocyanine (zinc phthalocyanine)IBA 03/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2021
1	Carbonic Anhydrase IXIBA 03/2021
1	Acetazolamide (Diamox)FDA LinkGeneric 03/2021
1	Hyaluronic Acid (Hyaluronan)IBA 03/2021
1	cardiotrophin-like cytokineIBA 01/2021
1	Axitinib (AG 013736)IBA 01/2021
1	pembrolizumabIBA 01/2021
1	Ciliary Neurotrophic Factor ReceptorIBA 01/2021
1	Chemokine CXCL6IBA 01/2021
1	VimentinIBA 11/2020
1	CateninsIBA 11/2020
1	Galectin 3 (LGALS3)IBA 11/2020
1	Sorafenib (BAY 43-9006)FDA Link 11/2020
1	AlkaloidsIBA 04/2016
1	epiberberineIBA 04/2016
1	palmatineIBA 04/2016
1	BerberineIBA 04/2016
1	jatrorrhizineIBA 04/2016
1	coptisineIBA 04/2016
1	RNA (Ribonucleic Acid)IBA 08/2015
1	titanium dioxide (Titania)FDA Link 02/2013
1	ParaffinIBA 06/2009
1	Insulin-Like Growth Factor I (IGF-1)IBA 06/2009
1	Insulin-Like PeptidesIBA 06/2009
1	matrigelIBA 10/2007
1	Transcription Factors (Transcription Factor)IBA 10/2007
1	Transforming Growth Factor beta (TGF-beta)IBA 03/2007
1	Interleukin-1 (Interleukin 1)IBA 03/2007
1	CCR2 ReceptorsIBA 12/2002
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 12/2002
1	Pertussis ToxinIBA 12/2002
1	Freund's AdjuvantIBA 12/2002

Therapy/Procedure

5	Therapeutics 10/2023 - 04/2016
5	Immunotherapy 10/2023 - 01/2021
3	Drug Therapy (Chemotherapy) 10/2023 - 10/2007
2	Radiotherapy 10/2023 - 11/2022
2	Photothermal Therapy 10/2023 - 03/2021
1	Photochemotherapy (Photodynamic Therapy) 10/2023
1	Microbubbles 01/2023
1	Lasers (Laser) 03/2021
1	Hysterectomy 06/2009
1	Injections 12/2002